Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

Journal of the American Medical Association

Volumn 288, Issue 7, 2002, Pages 862-871

  Annane, Djillali ^a   Sébille, Véronique ^b,i   Charpentier, Claire ^c   Bollaert, Pierre Edouard ^c   François, Bruno ^d   Korach, Jean Michel ^e   Capellier, Gilles ^f   Cohen, Yves ^g   Azoulay, Elie ^e   Troché, Gilles ^h   Chaumet Riffaut, Philippe ^e   Bellissant, Eric ^b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^g AVICENNE HOSPITAL   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

ⁱ UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; FLUDROCORTISONE; HYDROCORTISONE; HYPERTENSIVE AGENT; PLACEBO;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; INTENSIVE CARE UNIT; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SUPERINFECTION; SURVIVAL; TREATMENT OUTCOME;

EID: 0037151571     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.7.862     Document Type: Article

References (38)

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
2. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
3. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
4. Treating patients with severe sepsis
5. Steroid controversy in sepsis and septic shock: A meta-analysis
6. Corticosteroid treatment for sepsis: A critical appraisal and metaanalysis of the literature
7. Cortisol response to corticotropin and survival in septic shock
8. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
9. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock
10. Corticosteroid therapy in severe illness
11. An historical review of glucocorticoid treatment in sepsis. Disease pathophysiology and the design of treatment investigation
12. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve
13. Effect of hydrocortisone on phenylephrine - Mean arterial pressure dose-response relationship in septic shock
14. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
15. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
16. Adrenal insufficiency
17. Gram-negative bacteremia, I: Etiology and ecology
18. APACHE-acute physiology and chronic health evaluation: A physiologically based classification system
19. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study
20. The Logistic Organ Dysfunction system: A new way to assess organ dysfunction in the intensive care unit
21. Improved specificity of a new direct assay for urinary cortisol: Application in corticoid treated patients
22. Cortisol replacement in severely stressed patients
23. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome
24. A multiple testing procedure for clinical trials
25. Regression models and life-tables
26. Calculating the number needed to treat for trials where the outcome is time to an event
27. Local venous responses to endotoxin in humans
28. Effectiveness of betamethasone in management of severe infections: A double-blind study
29. The effects of high-dose corticosteroids in patients with septic shock: A prospective, controlled study
30. The cardiopulmonary response to massive doses of steroids in patients with septic shock
31. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
32. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis
33. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock
34. Hyperreninemic hypoaldosteronism in the critically ill: A new entity
35. The dissociation of renin and aldosterone during critical illness
36. Clinical implications of glucocorticoid metabolism by 11β-hydroxysteroid dehydrogenases in target tissues
37. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man
38. Effects of stress-dose hydrocortisone therapy in septic shock, I: Influence on hemodynamic stability and plasma nitrite/nitrate levels: Preliminary results of a double blind, randomised, placebo-controlled cross-over study